Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Carlsson

Showing results (41-50 of 664) with videos related to

Pageof 67
Sort By:
The Journal of Pharmacy and Pharmacology|October 1, 1970
Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slicesA Carlsson
Acta Neurologica Scandinavica. Supplementum|January 1, 1972
Biochemical and pharmacological aspects of ParkinsonismA Carlsson
Pharmacopsychiatry|March 2, 2006
The neurochemical circuitry of schizophreniaA Carlsson
Danish Medical Bulletin|February 1, 1985
Neurotransmitter changes in the aging brainA Carlsson
Acta Neuropsychiatrica|March 15, 2016
The prospects of new antipsychotic principlesA Carlsson
Gerontology|January 1, 1987
Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groupsA Carlsson
The American Journal of Psychiatry|February 1, 1978
Antipsychotic drugs, neurotransmitters, and schizophreniaA Carlsson
Journal of Neural Transmission|January 1, 1983
Dopamine receptor agonists: intrinsic activity vs. state of receptorA Carlsson
Advances in Neurology|January 1, 1993
Thirty years of dopamine researchA Carlsson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1988
The current status of the dopamine hypothesis of schizophreniaA Carlsson
Pageof 67

Showing results (41-50 of 664) with videos related to

Sort By:
Pageof 67
The Journal of Pharmacy and Pharmacology|October 1, 1970
Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slicesA Carlsson
Acta Neurologica Scandinavica. Supplementum|January 1, 1972
Biochemical and pharmacological aspects of ParkinsonismA Carlsson
Pharmacopsychiatry|March 2, 2006
The neurochemical circuitry of schizophreniaA Carlsson
Danish Medical Bulletin|February 1, 1985
Neurotransmitter changes in the aging brainA Carlsson
Acta Neuropsychiatrica|March 15, 2016
The prospects of new antipsychotic principlesA Carlsson
Gerontology|January 1, 1987
Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groupsA Carlsson
The American Journal of Psychiatry|February 1, 1978
Antipsychotic drugs, neurotransmitters, and schizophreniaA Carlsson
Journal of Neural Transmission|January 1, 1983
Dopamine receptor agonists: intrinsic activity vs. state of receptorA Carlsson
Advances in Neurology|January 1, 1993
Thirty years of dopamine researchA Carlsson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1988
The current status of the dopamine hypothesis of schizophreniaA Carlsson
Pageof 67